Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate Dihydrate Inhaler)

Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate Dihydrate Inhaler)
© The Swiss Pharmacy

Foracort Forte (Budesonide and Formoterol Fumarate
Dihydrate Inhaler is indicated in the regular treatment of
asthma in patients 12 years of age and older where use of
combination of inhaled regular corticosteroid & long acting
beta2-agonist is appropriate. Foracort Forte Inhaler is NOT
indicated for the relief of acute bronchospasm.
Foracort Forte Inhaler is indicated in patients with moderate
to severe Chronic Obstructive Pulmonary Disease (COPD)
with frequent symptoms and a history of exacerbations
Foracort Forte Inhaler is not recommended for children
under 12 years of age.

Foracort Forte Inhaler is
manufactured by Cipla Limited, India
in the following strength: Foracort
Forte (12 mcg of Formoterol Fumarate
Dihydrate and 400 mcg of Budesonide)
.

Chemical Structure - Budesonide

Chemical Structure - Formoterol Fumarate

The active ingredients
contained in Foracort
Inhaler are Budesonide And
Formoterol Fumarate
Dihydrate.
Each actuation of Foracort
inhaler contains 12 mcg of
Formoterol Fumarate
Dihydrate whereas the
quantity of Budesonide BP is
400 mcg respectively.

Uses of Foracort Forte Inhaler:
Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate
Dihydrate Inhaler) is used in the regular treatment of asthma in patients 18
years of age and older where use of a combination (inhaled corticosteroid
and long-acting beta2-agonist) is appropriate which include patients not
adequately controlled with inhaled corticosteroids and “as needed” inhaled
short-acting beta2-agonists or Patients already adequately controlled on
both inhaled corticosteroids and long-acting beta2-agonists.
Foracort Forte Inhaler is NOT indicated for the relief of acute bronchospasm.
This medicine is also used for the symptomatic treatment of patients with
severe COPD (FEV1 less than 70% predicted normal) and a history of
repeated exacerbations, who have significant symptoms despite regular
therapy with long-acting bronchodilators.
URL: https://www.theswisspharmacy.com/product_info.php?info=p9823_Foracort-Inhaler.html

Uses of Foracort Forte Inhaler:
Inhaled Budesonide belongs to the family of medicines known as
corticosteroids (cortisone-like medicines).
It works by preventing inflammation (swelling) in the lungs that
causes an asthma attack.
Inhaled Formoterol belongs to the family of medicines known as
bronchodilators.
It works by helping the muscles around the airways in your lungs stay
relaxed to prevent asthma symptoms, such as wheezing and
shortness of breath. This increases the flow of air through the
bronchial tubes.

Recommended Adult Dosage
Foracort Forte Inhaler (Generic Budesonide and Formoterol
Fumarate Dihydrate Inhaler) is not intended for the initial management
of asthma. The dosage of the components of Foracort Forte Inhaler is
individual and should be adjusted to the severity of the disease.
The recommended dosage for treatment of Asthma in adults (18 years
and older) is 1 inhalation twice daily. Some patients may require up to a
maximum of 2 inhalations twice daily.
The recommended dosage for treatment of COPD in adults (18 years
and older) is 1 inhalation twice daily.

Recommended Dosage - Children
The recommended dosage of Foracort Forte Inhaler (Generic
Budesonide and Formoterol Fumarate Dihydrate Inhaler) for
treatment of Asthma in adolescents (12 to 17 years) is 1 inhalation
twice daily.

Contraindications
➔
Foracort Forte Inhaler is contraindicated in patients with a
known hypersensitivity to Formoterol Fumarate Dihydrate,
Budesonide or any component of the inhaler.
➔
Administration of Foracort Forte Inhaler is also
contraindicated in patients that require primary treatment of
status asthmaticus acute episodes of asthma or COPD requiring
intensive measures.

Storage Instructions
Foracort Forte Inhaler (Generic Budesonide and
Formoterol Fumarate Dihydrate Inhaler) have to be
stored at controlled room temperature i.e. from 20°C
to 25°C (68°F to 77°F) with excursions permitted
between 15° to 30°C (59° to 86°F).
Keep this as well as all other medicines away from
children and pets.

Warnings
Serious asthma-related events: Long-acting beta2-adrenergic agonists as
monotherapy increase the risk.
Deterioration of disease and acute episodes: Do not initiate in acutely
deteriorating asthma or COPD or to treat acute symptoms.
Use with additional long-acting beta2-agonist: Do not use in combination
because of risk of overdose.
Localized infections: Candida albicans infection of the mouth and throat may
occur. Monitor patients periodically for signs of adverse effects on the oral
cavity. Advise the patient to rinse his/her mouth with water without
swallowing after inhalation to help reduce the risk.
Pneumonia: Increased risk in patients with COPD. Monitor patients for signs
and symptoms of pneumonia and other potential lung infections.

Warnings
Immunosuppression: Potential worsening of infections (e.g., existing
tuberculosis, fungal,bacterial, viral, or parasitic infection; or ocular herpes
simplex). Use with caution in patients
with these infections. More serious or even fatal course of chickenpox or
measles can occur in susceptible patients.
Transferring patients from systemic corticosteroids: Risk of impaired adrenal
function when transferring from oral steroids. Taper patients slowly from
systemic corticosteroids if transferring to Foracort Inhaler.
Hypercorticism and adrenal suppression: May occur with very high dosages or
at the regular dosage in susceptible individuals. If such changes occur,
discontinue Foracort Inhaler slowly.
Strong cytochrome P450 3A4 inhibitors (e.g., Ritonavir): Risk of increased
systemic corticosteroid effects. Exercise caution when used with Foracort
Inhaler.

Warnings
Paradoxical bronchospasm: Discontinue Foracort Forte Inhaler (Budesonide
and Formoterol Fumarate Dihydrate Inhaler) and institute alternative therapy if
paradoxical bronchospasm occurs.
Patients with cardiovascular or central nervous system disorders: Use with
caution because of beta-adrenergic stimulation.
Decreases in bone mineral density: Assess bone mineral density initially and
periodically thereafter.
Effects on growth: Monitor growth of pediatric patients.
Glaucoma and cataracts: Close monitoring is warranted.
Metabolic effects: Be alert to eosinophilic conditions, hypokalemia, and
hyperglycemia.
Coexisting conditions: Use with caution in patients with convulsive disorders,
thyrotoxicosis, diabetes mellitus, and ketoacidosis.

Possible Side Effects
Most common Formoterol Fumarate and Budesonide Inhaler
(Foracort Forte Inhaler) side effects with an incidence rate of 3%
or greater are:
Asthma: nasopharyngitis, headache, upper respiratory tract
infection, pharyngolaryngeal pain, sinusitis, influenza, back pain,
nasal congestion, stomach discomfort, vomiting, and oral
candidiasis.
COPD: nasopharyngitis, oral candidiasis, bronchitis, sinusitis,
upper respiratory tract infections.

Overdosage
An overdose of Formoterol would likely lead to effects that
are typical for beta2-adrenergic agonists: tremor, headache,
palpitations. Symptoms reported from isolated cases are
tachycardia, hyperglycemia, hypokalemia, prolonged QTc-
interval, arrhythmia, nausea and vomiting.
Supportive and symptomatic treatment may be indicated. A
dose of 90 mcg administered during three hours in patients
with acute bronchial obstruction raised no safety concerns.

Overdosage
Acute overdosage with Budesonide, even in excessive
doses, is not expected to be a clinical problem. When used
chronically in excessive doses, systemic
glucocorticosteroid effects, such as hypercorticism and
adrenal suppression, may appear.
If Foracort Forte (Generic Formoterol and Budesonide
Inhaler) therapy has to be withdrawn due to overdose of the
Formoterol component of the drug, provision of appropriate
inhaled corticosteroid therapy must be considered.

Treatment of Overdosage
Treatment of Formoterol overdosage consists of discontinuation of
the medication together with institution of appropriate symptomatic
and/or supportive therapy. The judicious use of a cardioselective beta-
receptor blocker may be considered, bearing in mind that such
medication can produce bronchospasm.
There is insufficient evidence to determine if dialysis is beneficial for
overdosage of Formoterol. Cardiac monitoring is recommended in
cases of overdosage.

Foracort Inhaler During Pregnancy
Budesonide and Formoterol Fumarate Dihydrate Inhaler (Foracort
Forte Inhaler) is classified by the US FDA as Pregnancy Category C.
No clinical data on exposed pregnancies are available with regard to
treatment with Formoterol and Budesonide combination medication.
There are no adequate data from use of Formoterol in pregnant
women.
In animal studies Formoterol has caused adverse effects in
reproduction studies at very high systemic exposure levels. Data on
approximately 2000 exposed pregnancies indicate no increased
teratogenic risk associated with the use of inhaled Budesonide. In
animal studies glucocorticosteroids have been shown to induce
malformations.

Foracort Forte Inhaler (Generic Budesonide
and Formoterol Fumarate Dihydrate Inhaler) is
manufactured by Cipla Limited, India.

Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate Dihydrate Inhaler)

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate Dihydrate Inhaler)

Similar to Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate Dihydrate Inhaler) (20)

More from The Swiss Pharmacy

More from The Swiss Pharmacy (20)

Recently uploaded

Recently uploaded (20)

Foracort Forte Inhaler (Generic Budesonide and Formoterol Fumarate Dihydrate Inhaler)